Overview

Overview

The Center for Urologic Oncology at the Glickman Urological & Kidney Institute is the largest center within the Department of Urology.

Download Our Free Treatment Guides

The membership of the Center boasts 10 fellowship-trained, internationally-recognized leaders in bladder, kidney, prostate, and testis cancer who are supported by an integrated team of experienced mid-level practitioners (including nurse practitioners and physicians assistants).

The surgeons within the Center perform robotic and open procedures to treat these cancers, often in a multi-disciplinary team approach with the integration of expertise by medical oncology and/or radiation oncology.

The Center has a rich history of technical innovations which have transformed the management of these cancers including open partial nephrectomy, laparoscopic/robotic partial nephrectomy, radical nephrectomy and venous thrombectomy for advanced kidney cancer, open/robotic radical prostatectomy and robotic radical cystectomy.

The Center has also been at the forefront of pioneering less-invasive treatment alternatives (where appropriate) for urologic cancers such as active surveillance, cryotherapy, and focal therapy for localized prostate cancer and percutaneous ablative procedures for small renal masses.

Annually, surgeons within the Center perform approximately 500 partial/radical nephrectomy procedures for kidney cancer, 450 prostatectomy procedures for prostate cancer, 140 cystectomy procedures for bladder cancer, and 40 retroperitoneal lymph node dissections for testis cancer.

The Center has unique expertise in managing rare urologic cancers (such as cancers of the penis, urethra, adrenal gland, and genitourinary sarcomas) and salvage procedures for recurrent cancers of the bladder and prostate that have failed initial therapy with radiation or other treatments.

The clinical activities of the Center are supported by world-class clinical experts in pathology, radiology, and anesthesia.

The Center also supports research programs in patient-centered outcomes research, prostate cancer/androgen receptor biology, and kidney cancer.

Prostate Cancer Nutrition Program

Prostate Cancer Nutrition Program

What you eat can impact your prostate cancer and certain foods may influence cancer survival.

About one in seven men will be diagnosed with prostate cancer at some point in their lives, according to the American Cancer Society. However, the simple act of eating the right foods can improve your chances of becoming a prostate cancer survivor.

Some foods fuel disease

Experts — backed by research — believe some foods can impact prostate cancer growth. Since sugary foods, red meat and dairy products are believed to provide fuel to cancer cells, prostate cancer patients are encouraged to modify their diet by:

  • Limiting red meat and eating it no more than two or three times per month.
  • Eating lots of fruits and vegetables.
  • Significantly limiting dairy and sugary foods.

Vitamins and supplements also play a role in prostate cancer

Including supplements and vitamins in your diet can also be beneficial.

  • Increase consumption of omega-3 fatty acids. Foods like salmon, chia seeds, sardines and flaxseeds are rich in omega-3s.
  • Decrease intake of omega-6 fatty acids. Foods like hamburgers, hot dogs, french fries and chicken wings are high in omega-6s.
  • Vitamin D also has shown to play a role in prostate cancer.

Cleveland Clinic Prostate Cancer Nutrition Program

David Levy, MD, a urologist in the Glickman Urological & Kidney Institute, has a special interest in the role foods and supplements play in prostate cancer and leads the Prostate Cancer Nutrition Program.  If you have or have had prostate cancer, or have a family history of prostate cancer, the Prostate Cancer Nutrition Program can help you understand whether diet and supplement changes might benefit you. For more information or to schedule an appointment, call 216.692.8900.

What We Treat

What We Treat

What is Open Partial Nephrectomy?

Conditions

Treatments and Procedures

For more information, view treatment guides from the Glickman Urological and Kidney Institute.

Our Team

Our Team

Andrew Stephenson , MD
Center Director, Center for Urologic Oncology
Eric Klein , MD
Chairman, Glickman Urological and Kidney Institute
J. Stephen Jones , MD
President, Regional Hospitals & Family Health Centers
Hui Zhu , MD
Contract Staff
Jihad Kaouk , MD
Director, Center for Robotic and Image Guided Surgery
Byron Lee , MD, PhD
Associate Staff
Research & Innovations

Research & Innovations

An overview video provides an example of calculation of the values from the planar CT images.

Kidney Tumor Location Measurement Using the C Index Method

A downloadable Microsoft® Excel spreadsheet is available to enable clinicians to rapidly determine 'C index' values from the 'y', 'x' and 'd' values of planar CT images.